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ABSTRACT 
Background: The efficacy of an extract from date seeds has been tested successfully on the 
glycemic control of type I diabetes mellitus in rats. A suggestion that date seed extract could 
stimulate certain cells to differentiate into insulin-secreting cells has been proposed. In order to 
investigate such a possibility, this study was conducted to measure C-peptide levels in the serum 
of type 1 diabetic rats treated with date seed extract. 
 
Methods: Two hundred rats were divided into 4 groups. Group I served as the control. Group II 
was given daily ingestions of 10 ml of date seed extract. Groups III and IV were made diabetic 
by streptozotocin injection and were given daily subcutaneous injections of 3 IU/day of insulin 
for 8 weeks. Group IV received, in addition, daily ingestions of 10 ml of seed extract. At the end 
of experiment, blood samples were collected from each rat, and blood glucose and serum C-
peptide levels were measured. 
 
Results: No significant differences in the means of blood glucose and serum C-peptide levels 
were observed between groups I (control group) and II (date seed extract-treated control group). 
Group  IV  (date  seed  extract-insulin-treated  diabetic  group)  showed  a  statistically  significant 
reduction in the mean blood glucose level compared to Group III (insulin-treated diabetic group). 
The mean serum C-peptide level was significantly higher in group IV compared to group III. 
 
Conclusion: Biochemical results suggested an increase in endogenous insulin secretion in the 
case  of  type  1  diabetic  rats  treated  with  date  seed  extract,  which  might  be  the  cause  of  its 
hypoglycemic effect. 
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BACKGROUND: 
Diabetes is a predominant public health concern affecting a large population in the whole world. 
The disease causes substantial morbidity, mortality, and long-term complications [1, 2].
 Insulin is 
the only drug currently available to treat type 1 diabetes mellitus (T1DM), and its disadvantages 
have been discussed in previous studies [3, 4]. There is an increasing use of complementary and 
alternative medicine among general public [5]. In a previous study, we successfully tested the 
efficacy of an aqueous extract from date seeds on the glycemic control of T1DM in rats [6].  
In another study, we demonstrated the safety of date seed extract administration on liver 
and kidneys of  rats, and showed that  a date seed extract-insulin combination  minimizes  the 
diabetic toxic effects on the liver and kidneys of rats, compared to insulin administration as a 
single  drug  [7].  However,  the  potential  mechanism  by  which  date  seed  extract  exerts  its 
hypoglycemic effect remains uninvestigated. A suggestion that such an extract could stimulate 
certain cells to differentiate into insulin-secreting cells has been proposed [6].  
C-peptide (connecting peptide), a 31-amino-acid polypeptide, represents the midportion 
of the proinsulin molecule. During insulin  secretion, it is  enzymatically  cleaved off and co-
secreted in equimolar proportion with mature insulin molecules. Because synthetic insulin does 
not have such a peptide, the level of C-peptide can show how much insulin is being secreted in 
the body [8]. The present study aimed to investigate the mechanism by which an extract of date 
seeds exerts its hypoglycemic effect, through measurements of C-peptide levels in serum of type 
1 diabetic rats treated with date seed extract. 
 
METHODS: 
Two hundred and fifty male adult Sprague Dawley albino rats weighing 250-300 g, obtained 
from the Animal House, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia, were 
used  in  this  study.  Principles  of  laboratory  animal  care  were  followed,  as  well  as  specific 
national laws were applicable. The study was first designed in 5 groups of 50 each. Rats in group 
V were diabetic taking daily ingestions of 10 ml of seed extract. However, most of the animals of 
this group died in the first 2 weeks of experiment. Thus, we excluded all animals of group V 
from the study. Therefore, the remaining two hundred rats were divided into 4 groups of 50 each. 
Group I was used as a control group that did not take either insulin or date seed extract. Group II  
was used as a control group that was given a daily ingestion of 10 ml of the date seed extract for 
8 weeks [6].  Group III  was treated with a daily subcutaneous injection of insulin. Group IV  
was  treated  with  a  daily  subcutaneous  injection  of  insulin  immediately  followed  by  a  daily 
ingestion of 10 ml of the date seed extract for 8 weeks. Diabetes mellitus was induced in groups 
III and IV by a single intravenous injection of freshly prepared streptozotocin (Sigma Chemical 
Co, St. Louis, Missouri, USA) at a dose of 60 mg/kg body weight dissolved in 0.1 mol/l citrate 
buffer (pH 4.5) [9]. Rats in groups I and II received an equivalent dose of the buffer. Animals 
with a blood glucose level higher than 300 mg/dl, 3 days after streptozotocin injection, were used 
in the experiment [10].  Diabetic rats in groups III and IV were treated with a daily subcutaneous 
injection of insulin glargine (Lantus, 100 IU/ml; Sanofi Aventis, Frankfurt, Germany). The dose 
of insulin was 3 IU/day/rat, in 2 divided doses for 8 weeks. The dose of insulin was adjusted to 
maintain  the  life  of  animals  (not  to  return  blood  glucose  to  normal)  [6].  At  the  end  of  the Functional Foods in Health and Disease 2013; 3(11):441-446                                                          Page 443 of 446 
experiment,  blood  glucose  levels  were  measured  using  Ascensia  contour  blood  glucose 
monitoring system (Bayer Health Care, Berkshire, UK).  
 
Determination of serum C-peptide levels: At the end of experiment, blood samples from each 
rat were collected into appropriately-labeled sterile tubes and allowed to clot, then left for 10 
minutes at room temperature for serum formation. The tubes were centrifuged at 3750 g for 5 
minutes. The sera were collected in appropriately-labeled tubes, kept frozen at -20°C, and then 
used for determination of C-peptide levels. Serum C-peptide concentrations were measured by 
radioimmunoassay according to the manufacturer’s instructions (Rat C-Peptide RIA KIT, Cat. # 
RCP-21K; Millipore, St. Charles, Missouri, USA). 
 
Statistical Analysis:  Data collected were subjected to statistical analysis using SPSS (PASW 
Statistics 18) software, where analysis of variance (ANOVA) was used for an overall comparison 
between the study groups, and the post hoc Tukey HSD test was used for pair wise comparisons. 
Differences were considered significant when p was less than or equal to 0.05.  
 
RESULTS: 
The mean fasting blood glucose level was significantly higher (p<0.05) in rats of groups III 
(insulin-treated diabetic group) and IV (date seed extract-insulin-treated diabetic group) when 
comparing each of them to those in groups I (control group) and II (date seed extract-treated 
control group). The mean fasting blood glucose level was significantly lower in group IV when 
compared to that in group III (p<0.05). No significant difference in mean fasting blood glucose 
levels was found between rats of groups I and II (p>0.05) (Fig. 1). 
 
Figure 1. Blood glucose levels (mean ± SD) (mg/dl) in all studied groups 
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        Significant difference compared to groups I & II. 
       †   Significant difference compared to group III. 
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No  significant  differences  (p>0.05)  in  mean  serum  C-peptide  level  were  observed 
between groups I and II. Groups III and IV showed a statistically significant reduction in serum 
C-peptide level (p<0.05) compared to groups I and II. The mean serum C-peptide level was 
significantly higher in group IV compared to group III (p<0.05) (Fig. 2). 
 
Figure 2. Serum C-peptide levels (mean ± SD) (pM) in all studied groups 
 
 
 
  Significant difference compared to groups I & II. 
 †   Significant difference compared to group III. 
 CTRL = Control; DS = Date seed; I = Insulin; DS + I = Date seed + Insulin 
 
DISCUSSION: 
The efficacy of an aqueous extract from date seeds has been tested successfully on the glycemic 
control of T1DM in rats [6]. The mean blood glucose levels were found to be significantly lower 
in diabetic rats treated with the date seed extract-insulin combination compared to insulin-treated 
diabetic rats. The safety of date seed extract administration on liver and kidney of rats was also 
demonstrated. In addition, the date seed extract-insulin combination was found to minimize the 
toxic  effects  of  diabetes  on  these  organs  [7].  The  previous  results  stimulated  the  authors  to 
conduct the present study, aiming to investigate the potential mechanism by which date seed 
extract exerts its hypoglycemic effect.  
A biochemical study was performed to measure the serum C-peptide levels in rats of 
control and diabetic groups. Evaluation of C-peptide level is a useful parameter to indicate the 
amount of endogenous insulin secreted in the body [11]. No significant differences in mean 
serum  C-peptide  levels  were  observed  between  control  groups  (group  I  and  II).  The  results 
obtained  after  the  measurement  of  serum  C-peptide  levels  were  in  accordance  with  those 
obtained after measurement of blood glucose levels in which no significant differences in mean Functional Foods in Health and Disease 2013; 3(11):441-446                                                          Page 445 of 446 
blood  glucose  levels  were  detected  between  the  control  groups.  Both  results  indicated  the 
absence of a hypoglycemic effect for the date seed extract when administered to normoglycemic 
animals.  The serum  blood glucose levels  were  significantly low,  while  the serum  C-peptide 
levels were significantly high in date seed extract-insulin-treated diabetic rats (group IV) when 
compared  to  those  obtained  in  insulin-treated  diabetic  rats  (group  III).  Biochemical  results 
suggested an increase in endogenous insulin secretion in case of diabetic rats treated with date 
seed  extract,  which  might  be  the  cause  of  its  hypoglycemic  effect,  and  subsequently  to  the 
significant reduction of mean blood glucose level in such rats, compared to those treated with 
insulin as a single drug. The effect of date seed extract on the control of hyperglycemia is further 
supported by our previous report [7], indicating that the combination of date seed extract and 
insulin minimizes the histopathological effects of diabetes on liver and kidney of diabetic rats 
when compared to insulin administration for the same period. 
  The  results  of  the  present  study  would  stimulate  the  conduction  of  an 
immunohistochemical study on the insulin-secreting cells (Beta cells) of the pancreatic islets of 
diabetic rats treated with date seed extract. Also, the present results would encourage further 
studies to investigate the effect of dosage variation and the duration of the administration of the 
date seed extract on type I diabetic rats. 
 
CONCLUSIONS: 
Date seed extract has a hypoglycemic effect on type 1 diabetic rats.  Date seed extract causes an 
increase in endogenous insulin secretion, which might be the cause of its hypoglycemic effect. 
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